- Home
- CMCL vs ESPR Comparison
CMCL vs ESPR Comparison
Compare CMCL & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCL
- ESPR
- Stock Information
- Founded
- CMCL 1992
- ESPR 2008
- Country
- CMCL Jersey
- ESPR United States
- Employees
- CMCL N/A
- ESPR N/A
- Industry
- CMCL Precious Metals
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- CMCL Basic Materials
- ESPR Health Care
- Exchange
- CMCL Nasdaq
- ESPR Nasdaq
- Market Cap
- CMCL 310.6M
- ESPR 319.2M
- IPO Year
- CMCL N/A
- ESPR 2013
- Fundamental
- Price
- CMCL $15.54
- ESPR $2.12
- Analyst Decision
- CMCL Buy
- ESPR Buy
- Analyst Count
- CMCL 1
- ESPR 4
- Target Price
- CMCL $13.50
- ESPR $8.17
- AVG Volume (30 Days)
- CMCL 76.7K
- ESPR 3.4M
- Earning Date
- CMCL 11-19-2024
- ESPR 11-07-2024
- Dividend Yield
- CMCL 3.60%
- ESPR N/A
- EPS Growth
- CMCL N/A
- ESPR N/A
- EPS
- CMCL 0.59
- ESPR N/A
- Revenue
- CMCL $159,880,000.00
- ESPR $295,451,000.00
- Revenue This Year
- CMCL $31.50
- ESPR $199.60
- Revenue Next Year
- CMCL $9.45
- ESPR $19.36
- P/E Ratio
- CMCL $26.13
- ESPR N/A
- Revenue Growth
- CMCL 23.43
- ESPR 187.12
- 52 Week Low
- CMCL $8.91
- ESPR $0.87
- 52 Week High
- CMCL $16.95
- ESPR $3.40
- Technical
- Relative Strength Index (RSI)
- CMCL 53.98
- ESPR 54.58
- Support Level
- CMCL $14.50
- ESPR $2.05
- Resistance Level
- CMCL $15.80
- ESPR $2.25
- Average True Range (ATR)
- CMCL 0.52
- ESPR 0.12
- MACD
- CMCL -0.15
- ESPR -0.00
- Stochastic Oscillator
- CMCL 42.45
- ESPR 61.54
About CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.